Trial site
Instituto Oncologico Dr. Rosell S.L.
- 12running trials
- 5closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Melanoma6 trials
- Ovarian cancer4 trials
- Childhood cancers2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Metastatic breast cancer1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 37 trials
- Phase 25 trials
- Phase 13 trials
- Phase 1/23 trials
- Status
- Active, not recruiting6 trials
- Completed5 trials
- Recruiting5 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Regeneron Pharmaceuticals2 trials
- AbbVie1 trial
- Ascendis Pharma Oncology Division A/S1 trial
- AstraZeneca AB1 trial
- Biocon Biologics UK PLC1 trial
- and 12 more
Running trials
Recruiting
Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Recruiting
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
A trial to learn how safe saruparib is and how well it works in people with advanced ovarian cancer
Active, not recruiting
Completed
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
Active, not recruiting
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 14 Nov 2026